Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

Introducing: Bloomberg This Weekend
01:08

California Attorney General Rob Bonta Talks Warner Bros./Paramount
07:54

Duolingo CEO Luis von Ahn Talks Earnings, AI
08:28